EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access

Evaluation of Cancer Survivors’ Experience of Using AI-Based Conversational Tools: Qualitative Study

Saif Khairat iD, Hanna Mehraby iD, Safoora Masoumi iD, Melissa Coffel iD, Callie Rockey-Bartlett iD, Andrea Huang iD, William Wood iD, Ethan Basch iD

JMIR Cancer · 14.11.2025 · 11 · e77390-e77390

DOI: 10.2196/77390 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift JMIR Cancer, online erschienen am 14.11.2025. Verfasst von Saif Khairat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Carolina Health Informatics Program, University of North Carolina at Chapel Hill, 428 Carrington Hall, Campus Box 7460, Chapel Hill, NC, 27514, Unite…. Hauptthemen laut MEDLINE: Cancer Survivors, Artificial Intelligence, Communication, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer survivorship is a complicated, chronic, and long-lasting experience, causing uncertainty and a wide range of physical and emotional health concerns. Due to the complexity of cancer, patients often seek out multiple sources of health information to better understand the aspects of their cancer diagnosis. The high variability among patients with cancer presents significant challenges in treatment, prognosis, and overall disease management. Artificial intelligence (AI) chatbots can further personalize cancer care delivery. However, there is a knowledge gap regarding cancer survivors’ perceived facilitators and barriers to adopting and using AI chatbots.

Objective

In this study, we examined cancer survivors’ experiences of using existing AI chatbots and identified their facilitators and barriers to the adoption of AI chatbots.

Methods

We conducted a qualitative study to investigate the perceptions of cancer survivors, conducting semistructured interviews to understand their prior use of existing AI chatbots in general. We asked the participants about their perceptions regarding AI chatbot acceptability and comfort level; trust and adherence; and concerns, barriers, and suggestions. We used the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist for this qualitative report.

Results

Of 21 participants, 17 (81%) were female patients with breast cancer, 15 (71%) were aged 50 to 64 years, 19 (90%) were White, and 9 (43%) had a graduate degree. Participants’ responses were grouped into three overarching themes: (1) patients’ perceptions of interacting with chatbots compared to health care professionals, (2) patient-chatbot interaction, and (3) chatbot information processing. All participants who were interviewed reported that they would prefer interacting with health care professionals over a chatbot. The lack of empathy shown by chatbots was a major concern among cancer survivors. Many patients criticized chatbots for tending to provide a general overarching response to their questions rather than being specific to their cancer diagnosis. The main concerns of cancer survivors with using chatbots were the overabundance of general information that was often not relevant to their diagnosis and privacy of patient information.

Conclusions

The findings of this study underscore the critical importance of empathetic responses during AI chatbot interactions for cancer survivors, as the lack of personalized and emotional responses can lead to distrust and frustration. Clinically, these tools should be integrated as supplementary resources to enhance patient engagement while preserving essential human support. Policymakers need to develop guidelines that promote responsible use of AI in cancer care, prioritizing patient confidentiality and trustworthiness. AI chatbots have the potential to significantly improve the support provided to cancer survivors, but it is crucial to address the identified barriers and enhance user acceptance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsArtificial IntelligenceCommunicationNeoplasmsHumansFemaleQualitative ResearchMiddle AgedMaleAgedAdult

Stichwörter der Autor:innen

adoptionartificial intelligencebarrierscancerfacilitatorssurvivorsuser experience

Autor:innen und Institutionen

  • Carolina Health Informatics Program, University of North Carolina at Chapel Hill, 428 Carrington Hall, Campus Box 7460, Chapel Hill, NC, 27514, United States, 1 9198435413.
  • School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Lineberger Comprehensive Care Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

ORCID-Profile: Saif Khairat, Hanna Mehraby, Safoora Masoumi, Melissa Coffel, Callie Rockey-Bartlett, Andrea Huang, William Wood, Ethan Basch

Förderung

  • NCATS NIH HHS

Zitieren

APA

Khairat, S., Mehraby, H., Masoumi, S., Coffel, M., Rockey-Bartlett, C., Huang, A., Wood, W., & Basch, E. (2025). Evaluation of Cancer Survivors’ Experience of Using AI-Based Conversational Tools: Qualitative Study. JMIR Cancer, 11, e77390-e77390. https://doi.org/10.2196/77390

Vancouver

Khairat S, Mehraby H, Masoumi S, Coffel M, Rockey-Bartlett C, Huang A, et al. Evaluation of Cancer Survivors’ Experience of Using AI-Based Conversational Tools: Qualitative Study. JMIR Cancer. 2025;11:e77390-e77390. doi:10.2196/77390

BibTeX
@article{Khairat2025,
  author = {Khairat, Saif and Mehraby, Hanna and Masoumi, Safoora and Coffel, Melissa and Rockey-Bartlett, Callie and Huang, Andrea and Wood, William and Basch, Ethan},
  title = {Evaluation of Cancer Survivors’ Experience of Using AI-Based Conversational Tools: Qualitative Study},
  journal = {JMIR Cancer},
  year = {2025},
  volume = {11},
  pages = {e77390--e77390},
  doi = {10.2196/77390}
}
Kostenlos starten →